Table 5.
Treatment and cause-specific mortality in the advanced age early stage non-small cell lung cancer cohort.
| Treatment | Death (not attributable to lung cancer) |
Death (attributable to lung cancer) |
||
|---|---|---|---|---|
| Deaths (N) | HR (95% CI) p-value | Deaths (N) | HR (95% CI) p-value | |
| Surgery only | 513 | 1 (Ref) | 557 | 1 (Ref) |
| Radiation only | 881 | 1.11 (0.97–1.26) 0.13 | 1,249 | 4.11 (4.11, 4.11) <0.0001 |
| Surgery + Radiation | 17 | 0.98 (0.59–1.636) 0.94 | 37 | 2.71 (2.71–2.71) <0.0001 |
| No treatment | 467 | 1.17 (1.00–1.38) 0.05 | 922 | 25.05 (25.05–25.05) <0.0001 |
HŖ hazard ratio; CI, confidence interval. Adjusted by age, race, sex, primary site, grade, laterality, histology, stage group, number of tumors, marital status, and chemotherapy.